% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{BlancDurand:850240, author = {Blanc-Durand, Paul and Van Der Gucht, Axel and Verger, Antoine and Langen, Karl-Josef and Dunet, Vincent and Bloch, Jocelyne and Brouland, Jean-Philippe and Nicod-Lalonde, Marie and Schaefer, Niklaus and Prior, John O.}, title = {{V}oxel-based 18{F}-{FET} {PET} segmentation and automatic clustering of tumor voxels: {A} significant association with {IDH}1 mutation status and survival in patients with gliomas}, journal = {PLoS one}, volume = {13}, number = {6}, issn = {1932-6203}, address = {Lawrence, Kan.}, publisher = {PLoS}, reportid = {FZJ-2018-04295}, pages = {e0199379 -}, year = {2018}, abstract = {IntroductionAim was to develop a full automatic clustering approach of the time-activity curves (TAC) from dynamic 18F-FET PET and evaluate its association with IDH1 mutation status and survival in patients with gliomas.MethodsThirty-seven patients (mean age: 45±13 y) with newly diagnosed gliomas and dynamic 18F-FET PET before any histopathologic investigation or treatment were retrospectively included. Each dynamic 18F-FET PET was realigned to the first image and spatially normalized in the Montreal Neurological Institute template. A tumor mask was semi-automatically generated from Z-score maps. Each brain tumor voxel was clustered in one of the 3 following centroids using dynamic time warping and k-means clustering (centroid #1: slowly increasing slope; centroid #2: rapidly increasing followed by slowly decreasing slope; and centroid #3: rapidly increasing followed by rapidly decreasing slope). The percentage of each dynamic 18F-FET TAC within tumors and other conventional 18F-FET PET parameters (maximum and mean tumor-to-brain ratios [TBRmax and TBRmean], time-to-peak [TTP] and slope) was compared between wild-type and IDH1 mutant tumors. Their prognostic value was assessed in terms of progression free-survival (PFS) and overall survival (OS) by Kaplan-Meier estimates.ResultsTwenty patients were IDH1 wild-type and 17 IDH1 mutant. Higher percentage of centroid #1 and centroid #3 within tumors were positively (P = 0.016) and negatively (P = 0.01) correlated with IDH1 mutated status. Also, TBRmax, TBRmean, TTP, and slope discriminated significantly between tumors with and without IDH1 mutation (P range 0.01 to 0.04). Progression occurred in 22 patients $(59\%)$ at a median of 13.1 months (7.6–37.6 months) and 13 patients $(35\%)$ died from tumor progression. Patients with a percentage of centroid #1 > $90\%$ had a longer survival compared with those with a percentage of centroid #1 < $90\%$ (P = 0.003 for PFS and P = 0.028 for OS). This remained significant after stratification on IDH1 mutation status (P = 0.029 for PFS and P = 0.034 for OS). Compared to other conventional 18F-FET PET parameters, TTP and slope were associated with PFS and OS (P range 0.009 to 0.04).ConclusionsBased on dynamic 18F-FET PET acquisition, we developed a full automatic clustering approach of TAC which appears to be a valuable noninvasive diagnostic and prognostic marker in patients with gliomas}, cin = {INM-4}, ddc = {500}, cid = {I:(DE-Juel1)INM-4-20090406}, pnm = {573 - Neuroimaging (POF3-573)}, pid = {G:(DE-HGF)POF3-573}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:29953478}, UT = {WOS:000436645400028}, doi = {10.1371/journal.pone.0199379}, url = {https://juser.fz-juelich.de/record/850240}, }